Hebei Senlang Biotechnology Inc., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Hebei China (2016)

Organization Overview

First Clinical Trial
2016
NCT02963038
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hebei Senlang BIotech Company | Hebei Senlang Biotechnology Inc., Ltd.